Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury

Sam Jacob, Donald J. Deyo, Robert A. Cox, Reuben K. Jacob, David Herndon, Daniel L. Traber, Hal K. Hawkins

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The recently developed murine model of smoke inhalation and burn (SB) injury was used to study the effect of the substance-P antagonist CP96345. C57BL/6 mice were pre-treated with an i.v. dose of a specific NK-1 receptor antagonist, CP9635, or its inactive enantiomer, CP96344, (10 mg/Kg) 1 h prior to SB injury per protocol (n = 5). Mice were anesthetized and exposed to cooled cotton smoke, 2X 30 s, followed by a 40% total body surface area flame burn per protocol. At 48 h after SB injury Evans Blue (EB) dye and myeloperoxidase (MPO) were measured in lung after vascular perfusion. Lungs were also analyzed for hemoglobin (Hb) and wet/dry weight ratio. In the current study, CP96345 pre-treatment caused a significant decrease in wet/dry weight ratio (23%, p = 0.048), EB (31%, p = 0.047), Hb (46%, p = 0.002), and MPO (54%, p = 0.037) levels following SB injury compared to animals with SB injury alone. CP-96344 pre-treatment caused an insignificant decrease in wet/dry weight ratio (14%, p = 0.18), EB (16%, p = 0.134), Hb (9%, p = 0.39), and an insignificant increase in MPO (4%, p = 0.79) as compared to mice that received SB injury alone. As expected, levels of EB, Hb, MPO, and wet/dry weight ratios were all significantly (p < 0.05) increased 48 h following SB injury alone compared to respective sham animals. In conclusion, the current study indicates that pre-treatment with a specific NK-1R antagonist CP-96345 attenuates the lung injury and inflammation induced by SB injury in mice.

Original languageEnglish (US)
Pages (from-to)197-203
Number of pages7
JournalToxicology Mechanisms and Methods
Volume20
Issue number4
DOIs
StatePublished - May 2010

Fingerprint

Inhalation Burns
Smoke Inhalation Injury
Evans Blue
Stereoisomerism
Substance P
Smoke
Peroxidase
Blood Vessels
Hemoglobins
Inflammation
Lung
Wounds and Injuries
Animals
Neurokinin-1 Receptors
Weights and Measures
Enantiomers
Cotton
Coloring Agents
CP 96345
Body Surface Area

Keywords

  • Acute lung injury
  • Burn injury
  • CP-96344
  • CP-96345
  • Myeloperoxidase
  • Neurogenic inflammation
  • NK-1 receptor antagonist
  • Plasma extravasation
  • Smoke inhalation
  • Substance P
  • Vascular permeability

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury. / Jacob, Sam; Deyo, Donald J.; Cox, Robert A.; Jacob, Reuben K.; Herndon, David; Traber, Daniel L.; Hawkins, Hal K.

In: Toxicology Mechanisms and Methods, Vol. 20, No. 4, 05.2010, p. 197-203.

Research output: Contribution to journalArticle

Jacob, Sam ; Deyo, Donald J. ; Cox, Robert A. ; Jacob, Reuben K. ; Herndon, David ; Traber, Daniel L. ; Hawkins, Hal K. / Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury. In: Toxicology Mechanisms and Methods. 2010 ; Vol. 20, No. 4. pp. 197-203.
@article{fa898f7660ea48588637671fac679207,
title = "Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury",
abstract = "The recently developed murine model of smoke inhalation and burn (SB) injury was used to study the effect of the substance-P antagonist CP96345. C57BL/6 mice were pre-treated with an i.v. dose of a specific NK-1 receptor antagonist, CP9635, or its inactive enantiomer, CP96344, (10 mg/Kg) 1 h prior to SB injury per protocol (n = 5). Mice were anesthetized and exposed to cooled cotton smoke, 2X 30 s, followed by a 40{\%} total body surface area flame burn per protocol. At 48 h after SB injury Evans Blue (EB) dye and myeloperoxidase (MPO) were measured in lung after vascular perfusion. Lungs were also analyzed for hemoglobin (Hb) and wet/dry weight ratio. In the current study, CP96345 pre-treatment caused a significant decrease in wet/dry weight ratio (23{\%}, p = 0.048), EB (31{\%}, p = 0.047), Hb (46{\%}, p = 0.002), and MPO (54{\%}, p = 0.037) levels following SB injury compared to animals with SB injury alone. CP-96344 pre-treatment caused an insignificant decrease in wet/dry weight ratio (14{\%}, p = 0.18), EB (16{\%}, p = 0.134), Hb (9{\%}, p = 0.39), and an insignificant increase in MPO (4{\%}, p = 0.79) as compared to mice that received SB injury alone. As expected, levels of EB, Hb, MPO, and wet/dry weight ratios were all significantly (p < 0.05) increased 48 h following SB injury alone compared to respective sham animals. In conclusion, the current study indicates that pre-treatment with a specific NK-1R antagonist CP-96345 attenuates the lung injury and inflammation induced by SB injury in mice.",
keywords = "Acute lung injury, Burn injury, CP-96344, CP-96345, Myeloperoxidase, Neurogenic inflammation, NK-1 receptor antagonist, Plasma extravasation, Smoke inhalation, Substance P, Vascular permeability",
author = "Sam Jacob and Deyo, {Donald J.} and Cox, {Robert A.} and Jacob, {Reuben K.} and David Herndon and Traber, {Daniel L.} and Hawkins, {Hal K.}",
year = "2010",
month = "5",
doi = "10.3109/15376511003674657",
language = "English (US)",
volume = "20",
pages = "197--203",
journal = "Toxicology Mechanisms and Methods",
issn = "1537-6516",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury

AU - Jacob, Sam

AU - Deyo, Donald J.

AU - Cox, Robert A.

AU - Jacob, Reuben K.

AU - Herndon, David

AU - Traber, Daniel L.

AU - Hawkins, Hal K.

PY - 2010/5

Y1 - 2010/5

N2 - The recently developed murine model of smoke inhalation and burn (SB) injury was used to study the effect of the substance-P antagonist CP96345. C57BL/6 mice were pre-treated with an i.v. dose of a specific NK-1 receptor antagonist, CP9635, or its inactive enantiomer, CP96344, (10 mg/Kg) 1 h prior to SB injury per protocol (n = 5). Mice were anesthetized and exposed to cooled cotton smoke, 2X 30 s, followed by a 40% total body surface area flame burn per protocol. At 48 h after SB injury Evans Blue (EB) dye and myeloperoxidase (MPO) were measured in lung after vascular perfusion. Lungs were also analyzed for hemoglobin (Hb) and wet/dry weight ratio. In the current study, CP96345 pre-treatment caused a significant decrease in wet/dry weight ratio (23%, p = 0.048), EB (31%, p = 0.047), Hb (46%, p = 0.002), and MPO (54%, p = 0.037) levels following SB injury compared to animals with SB injury alone. CP-96344 pre-treatment caused an insignificant decrease in wet/dry weight ratio (14%, p = 0.18), EB (16%, p = 0.134), Hb (9%, p = 0.39), and an insignificant increase in MPO (4%, p = 0.79) as compared to mice that received SB injury alone. As expected, levels of EB, Hb, MPO, and wet/dry weight ratios were all significantly (p < 0.05) increased 48 h following SB injury alone compared to respective sham animals. In conclusion, the current study indicates that pre-treatment with a specific NK-1R antagonist CP-96345 attenuates the lung injury and inflammation induced by SB injury in mice.

AB - The recently developed murine model of smoke inhalation and burn (SB) injury was used to study the effect of the substance-P antagonist CP96345. C57BL/6 mice were pre-treated with an i.v. dose of a specific NK-1 receptor antagonist, CP9635, or its inactive enantiomer, CP96344, (10 mg/Kg) 1 h prior to SB injury per protocol (n = 5). Mice were anesthetized and exposed to cooled cotton smoke, 2X 30 s, followed by a 40% total body surface area flame burn per protocol. At 48 h after SB injury Evans Blue (EB) dye and myeloperoxidase (MPO) were measured in lung after vascular perfusion. Lungs were also analyzed for hemoglobin (Hb) and wet/dry weight ratio. In the current study, CP96345 pre-treatment caused a significant decrease in wet/dry weight ratio (23%, p = 0.048), EB (31%, p = 0.047), Hb (46%, p = 0.002), and MPO (54%, p = 0.037) levels following SB injury compared to animals with SB injury alone. CP-96344 pre-treatment caused an insignificant decrease in wet/dry weight ratio (14%, p = 0.18), EB (16%, p = 0.134), Hb (9%, p = 0.39), and an insignificant increase in MPO (4%, p = 0.79) as compared to mice that received SB injury alone. As expected, levels of EB, Hb, MPO, and wet/dry weight ratios were all significantly (p < 0.05) increased 48 h following SB injury alone compared to respective sham animals. In conclusion, the current study indicates that pre-treatment with a specific NK-1R antagonist CP-96345 attenuates the lung injury and inflammation induced by SB injury in mice.

KW - Acute lung injury

KW - Burn injury

KW - CP-96344

KW - CP-96345

KW - Myeloperoxidase

KW - Neurogenic inflammation

KW - NK-1 receptor antagonist

KW - Plasma extravasation

KW - Smoke inhalation

KW - Substance P

KW - Vascular permeability

UR - http://www.scopus.com/inward/record.url?scp=77955299850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955299850&partnerID=8YFLogxK

U2 - 10.3109/15376511003674657

DO - 10.3109/15376511003674657

M3 - Article

C2 - 20201741

AN - SCOPUS:77955299850

VL - 20

SP - 197

EP - 203

JO - Toxicology Mechanisms and Methods

JF - Toxicology Mechanisms and Methods

SN - 1537-6516

IS - 4

ER -